1. BESTEST®: a new diagnostic opportunity for bone structure evaluation in oncology. (March 2019) Authors: Saracchini, S.; Del Conte, A.; Foltran, L.; Corsetti, S.; Cosmi, F. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A "real life" study. (February 2017) Authors: Giordano, G.; Lo Re, G.; Milella, M.; Di Marco, M.; Melisi, D.; Passardi, A.; Iop, A.; Febbraro, A.; Foltran, L.; Francesca, B.; Bertocchi, P.; Vaccaro, V.; Aloi, M.B.; Giommoni, E.; Ricci, V.; Vasile, E.; Zaniboni, A.; Zagone, V.; De Vita, F. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-0777: Intensified IMRT with concurrent chemotherapy for locally advanced esophageal carcinoma. (April 2018) Authors: Innocente, R.; Navarria, F.; Palazzari, E.; Matrone, F.; Boz, G.; Gigante, M.; Farina, E.; Foltran, L.; Castoro, C.; Ubiali, P.; Petri, R.; Ruol, A.; Franchin, G.; De Paoli, A. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-1112: Total neoadjuvant therapy in high risk rectal cancer: a feasibility pilot study. (November 2020) Authors: Palazzari, E.; Buonadonna, A.; Lauretta, A.; Navarria, F.; Ongaro, E.; Foltran, L.; Innocente, R.; Belluco, C.; Ubiali, P.; Canzonieri, V.; Urbani, M.; Colombo, C.; Bertola, G.; De Paoli, A. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. T02.02.19 CLINICAL AND MOLECULAR CHARACTERIZATION OF A NEW KIT-MUTATED FAMILIAL GASTROINTESTINAL STROMAL TUMOR: A PRACTICAL APPROACH TO A RARE CONDITION. (1st October 2020) Authors: Campigotto, M.; Foltran, L.; Gasparotto, D.; Maestro, R.; Cannizzaro, R.; Colombo, A.; Visintin, A.; Fornasarig, M. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗